Skip to content

Thursday, October 29, 2026

Top Stories Global Economy Markets Topics & Series Contributors Opinion

All desks ⌄

Economy & Finance

Economy Investing Central Banks Digital Currency Fintech Research & Analysis Technicals

Power & Business

Politics Business Law Insights & Views Governance Market Roundups

Science & Society

Technology Science Nature Health Life

In focus · trending topic

GC Biopharma

1 stories · following the connections

A laboratory worker places a sample vial in a rack at a biotechnology facility in Yongin, South Korea. (AI-generated image / EconoTimes)

BioMarin Secures Fabry Therapy License With $70 Million Upfront

By Naomi CalderOct 29, 2026, 5:04 PM UTC

←1→Page 1 of 1

Connected markets

Follow the indicators behind the story.

Illustrative data · 06 Oct 2026, 08:00 UTC

Keep exploring

GDP Al Jazeera U.S. economy Federal Reserve Bank of Japan U.S. midterms Political donors Money Works

Coverage

Global Economy Markets Technology Politics All news

Intelligence

Topics & Series Contributors Research

Company

About us Become a contributor Contact info@econotimes.com Editorial standards

© 2026 Econometrics LLC. 21 Penn Plaza New York, NY United States 10001Privacy Terms of use Our standards

Home Markets Topics Search